Elizabeth Chamblee Birch, law professor and author of The Pain Brokers, exposes a coordinated healthcare fraud scheme targeting over 100,000 women. Stolen HIPAA-protected health records were weaponized by call centers in India and South Florida to convince women they needed emergency mesh removal surgery. Many women were left permanently incontinent after unnecessary procedures. The scheme involved call centers using stolen medical data, South Florida surgical operations, lawyers creating hidden liens, and litigation funders profiting from women's suffering. Birch introduces the villains: Vince Chabra (online pill mill founder), Blake Barber (travel concierge), and complicit doctors. She also highlights heroes: Barbara Bennis (defense attorney who uncovered the conspiracy) and J.R. Baxter (young plaintiffs lawyer who fought back). The episode reveals how electronic health record systems enabled massive data breaches, how private equity infiltrated the legal system, and what reforms are desperately needed to prevent future schemes.

Key Timestamps

0:53 Joe Grogan introduction

1:25 Joe asks Elizabeth about her background

1:37 Elizabeth's background: 21 years teaching mass torts

2:25 Elizabeth's MFA in narrative nonfiction at UGA

3:26 What is vaginal mesh used for?

5:21 Sharon gets intimate stolen medical data in phone call

6:00 Sharon didn't know she had mesh inserted

6:32 Call centers in India and South Florida

7:32 Alpha Law: Frankenstein firm through D.C. loophole

9:31 Outbound calls fueled by illegal stolen HIPAA data

10:12 Sharon's journey through the system

12:39 Sharon's financial devastation: $69-120K lien

13:24 Litigation funders threaten Sharon's house after settlement

15:00 Multi-district litigation vs class action

16:15 The perverse economics of the scheme

17:33 Economics: $15K vs $215K+ for removal

19:10 Women left permanently incontinent after unnecessary surgeries

21:15 Meet Vince Chabra and Blake Barber: the kingpins

26:11 Wolf of Wall Street moment: 14,000 claims for $40 million

27:45 Cold called over 100,000 women, signed 14,000 as clients

28:35 Barbara Bennis: defense attorney hero discovers conspiracy

30:37 Jerry Plummer and J.R. Baxter: young lawyer fighting back

34:36 Electronic health records enabled the data breach

36:07 Women receive $40K average settlement before fees

37:30 Data bias in medicine: gender gap in settlements

42:37 Solutions: anti-kickback statute reform

43:35 Private equity infiltrating law firms: the next frontier

Key Topics

Vaginal mesh litigation, healthcare fraud, HIPAA violations, stolen health records, call center fraud, litigation funding, private equity, women's health bias, legal reform, unnecessary surgery, settlement bias, data breach, electronic health records

Podcast: DC EKG with Joe Grogan | Episode: 139 | Host: Joe Grogan | Guest: Elizabeth Chamblee Birch, Law Professor, University of Georgia

Sponsor: Survivors for Solutions – https://survivorsforsolutions.org

Executive Producer: John "CZ" Czwartacki, DC EKG Podcast

Producer: Stay on Course Studios – https://www.stayoncourse.studio

Guest: John Bertrand, former Digital Diagnostics

Episode Description

Joe Grogan sits down with John Bertrand, a veteran healthcare technology executive who scaled Digital Diagnostics to 75 health systems and achieved the first FDA approval and CMS reimbursement for an autonomous AI diagnostic device without a physician in the diagnostic loop. Bertrand reveals the harsh realities of bringing AI innovation to market: FDA and CMS regulatory frameworks are built for traditional medical devices and physician-driven care, not autonomous AI diagnostics. The conversation covers the shocking CMS reimbursement draft that came in 40-60% below cost of goods sold, the massive first-mover disadvantage in regulated medical device AI, and why reimbursement is the true gating factor for adoption—not clinical superiority. Bertrand explains how workflow integration and financial incentives matter far more than being clinically better. The episode explores the massive gap between what entrepreneurs think should happen with new innovations and the regulatory reality. He concludes with a sobering assessment: if building diagnostic AI again, he would choose supply chain automation instead because the regulatory and reimbursement headwinds are so significant they punish innovators. Where AI is actually making an impact today is patient-facing triage agents, administrative automation, and revenue cycle management—areas with far less friction.

KEY TIMESTAMPS

0:40 Joe introduces John Bertrand and his healthcare tech background

1:28 John clarifies he recently left Digital Diagnostics for supply chain work

2:40 John's career: 13 years at Epic Systems across multiple roles

6:10 What does Digital Diagnostics' AI device do? Automating retinal imaging

7:56 First FDA approval and first CMS reimbursement for autonomous AI diagnostic

9:02 Joe's threshold question: shouldn't better innovation be easily adopted?

9:50 Reality: workflow integration and reimbursement matter more than clinical quality

11:50 The adoption curve: all successful FDA-approved AI devices have CMS reimbursement

14:10 FDA experience: desire to help but frameworks built for old technology

15:40 FDA scrutiny on AI exceeds scrutiny on human clinicians

18:05 FDA guidance changes every 6-12 months, creating constant pivoting and delays

20:08 Shifting to CMS: the shocking draft reimbursement story

20:45 Draft came in at $10 per test, needed $30+ to be viable

22:42 Four months of negotiations with CMS to shift value argument

24:40 Process not codified: each company follows unique regulatory path

28:04 Six years at Digital Diagnostics: was it worth it?

28:44 John would not recommend diagnostic AI to new founders

33:02 Turning down multiple diagnostic AI opportunities post-Digital Diagnostics

34:19 AI hype vs reality: where are patients actually seeing life improvements?

34:19 Patient-facing triage agents are the second inning of real AI opportunity

36:25 Reimbursement for chat-based triage: who gets paid?

38:23 Autonomous vs assistive AI: the regulatory gap that exists

40:31 Could Digital Diagnostics have done physician-in-loop from the start?

41:33 Real opportunity: clinical practices deploying their own AI

42:20 State licensing nightmare: deploying AI across 50 states

44:55 The real concern: RCM automation becoming a zero-sum AI bot battle

45:20 Dead Internet Theory applied to healthcare revenue cycle

47:38 Closing: a tour de force on AI healthcare reality

Key Topics

AI in healthcare, FDA approval process, CMS reimbursement, autonomous AI diagnostics, Digital Diagnostics, diabetic retinopathy, regulatory frameworks, first-mover disadvantage, workflow integration, reimbursement strategy, patient-facing AI, healthcare innovation, regulatory friction, adoption barriers, state licensing, RCM automation, healthcare AI reality

About the Guest

John Bertrand is a veteran healthcare technology executive with over 20 years of experience. He spent 13 years at Epic Systems in analyst, product manage